Novartis AG

In News

NVS Stock Price, Quote & Chart | NOVARTIS AG-SPONSORED ADR (NYSE:NVS) - ChartMill

ChartMill - May 29, 2026

Pushing the prostate cancer treatment frontier: Radioligand therapy and beyond - Novartis

Novartis - May 28, 2026

Novartis AG (NVS) Expands U.S. Manufacturing Footprint with New Texas Site - Yahoo Finance

Yahoo Finance - May 11, 2026

Novartis’ experimental prostate cancer drug shows promise - Investing.com

Investing.com - May 31, 2026

Novartis AG Announces Intention to Separate Sandoz Business to Create a Standalone Company Call - Media Transcript - GuruFocus

GuruFocus - May 27, 2026

NOVARTIS AG : Deutsche Bank reiterates its Buy rating - marketscreener.com

marketscreener.com - May 27, 2026

Novartis sales fall as blockbuster patents expire - Financial Times

Financial Times - Apr 28, 2026

Avidity Biosciences Enters into Agreement to be Acquired by Novartis AG - PR Newswire

PR Newswire - Oct 26, 2025

Novartis, Roche Near US Drug Price Deal in Easing of Swiss Trade Tensions - Bloomberg.com

Bloomberg.com - Dec 18, 2025

Global pharma company Novartis plans $220-million RTP investment - Spectrum News

Spectrum News - May 06, 2026

Novartis to buy experimental breast cancer drug in up to $3 billion deal - Reuters

Reuters - Mar 20, 2026

Case overview: Novartis AG and Genentech v SHARx and Campbell Heights Pharmacy (2026 — ) – ongoing - Partnership for Safe Medicines

Partnership for Safe Medicines - Feb 25, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment